A team of scientists is to try to develop a wholly artificial vaccine to combat polio.
Scientists from the US and UK hope to create a safe vaccine by copying the viral genome, rather than having a tiny portion of the disease present in the vaccine, the Independent reported.
Researcher Dave Stuart said that the idea of the synthetic vaccine is that it contains no genome as it's virus free and so it's made, in a way, like a super-chemical, a complicated chemical, that assembles itself to look like the virus but has no way of ever replicating.
Stuart, who is hopeful about their prospects, added that early results with polio are very promising, with synthetic particles being produced and evidence of successful stabilisation.
The scientists hope by artificially replicating the virus, in effect removing its genetic machinery, they can avoid using a weakened version of the virus in the oral medication used today.
In a small number of cases the oral medication provokes a reaction in the patient's gut which allows a reactivated virus to pass out of the body and spread to other unvaccinated individuals.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
